Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard I Evan

Cancer cell

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Cell|November 14, 2006
Can't kick that oncogene habitGerard I Evan
Cancer Cell|August 12, 2008
The ever-lengthening arm of p53Gerard I Evan
Cancer Cell|June 28, 2002
A matter of life and deathDouglas R Green, Gerard I Evan
Cancer Cell|September 21, 2002
The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivoEmmy W Verschuren, Juha Klefstrom, Gerard I Evan, et al.
Cancer Cell|December 13, 2006
Mdm2 is critically and continuously required to suppress lethal p53 activity in vivoIngo Ringshausen, Clodagh C O'Shea, Andrew J Finch, et al.
Cancer Cell|August 15, 2006
Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanismsAndrew Finch, Julia Prescott, Ksenya Shchors, et al.
Cancer Cell|December 9, 2008
Distinct thresholds govern Myc's biological output in vivoDaniel J Murphy, Melissa R Junttila, Laurent Pouyet, et al.
Cancer Cell|October 16, 2007
Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulationKoji Itahana, Hua Mao, Aiwen Jin, et al.
Cancer Cell|December 19, 2015
A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast CancerBjörn von Eyss, Laura A Jaenicke, Roderik M Kortlever, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Cell|November 14, 2006
Can't kick that oncogene habitGerard I Evan
Cancer Cell|August 12, 2008
The ever-lengthening arm of p53Gerard I Evan
Cancer Cell|June 28, 2002
A matter of life and deathDouglas R Green, Gerard I Evan
Cancer Cell|September 21, 2002
The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivoEmmy W Verschuren, Juha Klefstrom, Gerard I Evan, et al.
Cancer Cell|December 13, 2006
Mdm2 is critically and continuously required to suppress lethal p53 activity in vivoIngo Ringshausen, Clodagh C O'Shea, Andrew J Finch, et al.
Cancer Cell|August 15, 2006
Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanismsAndrew Finch, Julia Prescott, Ksenya Shchors, et al.
Cancer Cell|December 9, 2008
Distinct thresholds govern Myc's biological output in vivoDaniel J Murphy, Melissa R Junttila, Laurent Pouyet, et al.
Cancer Cell|October 16, 2007
Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulationKoji Itahana, Hua Mao, Aiwen Jin, et al.
Cancer Cell|December 19, 2015
A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast CancerBjörn von Eyss, Laura A Jaenicke, Roderik M Kortlever, et al.
Pageof 1